Science

Sarbajit Mukherjee: Excited to share my 50th publication from Roswell Park

Sarbajit Mukherjee/LinkedIn

Jan 16, 2025, 09:48

Sarbajit Mukherjee: Excited to share my 50th publication from Roswell Park

Sarbajit Mukherjee, Associate Professor and Co-Leader of GI Translational Research Group at Roswell Park shared a recent article by him and colleagues on X:

“Excited to share my 50th publication from Roswell Park.

This clinical trial represents years of hard work, and I’m so grateful to my mentor Dr. Renuka Iyer, Ipsen, NANETS and the patients and families who supported this journey.”

“Phase II Study of Nanoliposomal Irinotecan (Nal-IRI) with 5-Fluorouracil and Leucovorin in Refractory Advanced High-Grade Neuroendocrine Cancer of Gastroenteropancreatic (GEP) or Unknown Origin“

Authors: Sarbajit Mukherjee, Harsha Pattnaik, Sahithi Sonti, Mrinalini Ramesh, Prantesh Jain, Robert A. Ramirez, Christos Fountzilas, Deepak Vadehra, Kristopher Attwood and Renuka Iyer

Sarbajit Mukherjee

For more updates, follow OncoDaily.

5-Fluorouracil cancer clinical trial Harsha Pattnaik Ipsen Kristopher Attwood leucovorin Mrinalini Ramesh NANETS Nanoliposomal Irinotecan neuroendocrine cancer OncoDaily Oncology Renuka Iyer Roswell Park Sahithi Sonti Sarbajit Mukherjee

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

Highlights from ELCC 2025

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

Meet the New AACR Board of Directores for 2025-2028 Term

Do Artificial Sweeteners Cause Cancer? Myths and Facts